TGFB1 and inflammatory bowel disease: RA and TGF-β coordinately provide a third mechanism, especially in IBD, effectively blocking the conversion of naive T-cells in the periphery into TH17-type cells and instead directing them into potently suppressive Foxp3+ Tregs (74, 75, 102).